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Spectrochemical analysis of liquid 
biopsy harnessed to multivariate 
analysis towards breast cancer 
screening
Daniel L. D. freitas1, ingrid M. câmara1, priscila p. Silva1, nathália R. S. Wanderley2, 
Maria B. c. Alves3,4, camilo L. M. Morais5,6, francis L. Martin5,6, tirzah B. p. Lajus2,3,4 & 
Kassio M. G. Lima1*
Mortality due to breast cancer could be reduced via screening programs where preliminary clinical 
tests employed in an asymptomatic well-population with the objective of identifying cancer 
biomarkers could allow earlier referral of women with altered results for deeper clinical analysis and 
treatment. the introduction of well-population screening using new and less-invasive technologies 
as a strategy for earlier detection of breast cancer is thus highly desirable. Herein, spectrochemical 
analyses harnessed to multivariate classification techniques are used as a bio-analytical tool for a 
Breast cancer Screening program using liquid biopsy in the form of blood plasma samples collected 
from 476 patients recruited over a 2-year period. This methodology is based on acquiring and 
analysing the spectrochemical fingerprint of plasma samples by attenuated total reflection Fourier-
transform infrared spectroscopy; derived spectra reflect intrinsic biochemical composition, generating 
information on nucleic acids, carbohydrates, lipids and proteins. excellent results in terms of 
sensitivity (94%) and specificity (91%) were obtained using this method in comparison with traditional 
mammography (88–93% and 85–94%, respectively). Additional advantages such as better disease 
prognosis thus allowing a more effective treatment, lower associated morbidity, fewer false-positive 
and false-negative results, lower-cost, and higher analytical frequency make this method attractive 
for translation to the clinical setting.
Breast cancer is the second most common and the leading cause of cancer-related death amongst  women1. 
According to the Brazilian Mortality Information System, 14,206 women died in 2013 due to this  disease2. In 
2014, the estimation was about 49,240 cases, and in 2018 it was expected to reach 59,700 new cases of breast 
cancer in Brazil  alone1. This neoplasm is relatively rare in women < 35 years old, and increases progressively 
above this age, especially after age 50 years3. Therefore, breast cancer is a major public health problem taking 
into consideration the detection and treatment  costs4. The control of breast cancer has been a priority and is 
present in the Brazilian Strategic Action Plan for Confronting Non-transmissible Chronic Diseases since  20115.
Only one in three cases of breast cancer can be cured if discovered at an early  stage2 and there are no effective 
ways of reducing the incidence of this  disease6. The best alternative approach to tackle breast cancer is the concept 
that the earlier the disease is detected, the more effective is the treatment. Early detection through screening is the 
only method that has proven to be effective in reducing  mortality1. Screening programs are an important health 
policy practice where the asymptomatic phase of disease is long enough to allow direct or indirect detection of 
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pre-cancerous lesions. A significant degree of transformation in such lesions found in this phase would allow 
determination of their clinical significance and implementation of effective treatment to improve the patient’s 
prognosis. Such a screening test that diagnoses early disease needs to be acceptable to patients and available at 
a reasonable  cost5.
Mammography is the recommended method for routine screening of breast cancer  worldwide6. This tech-
nique performed with an x-ray machine is described as a radiological examination for evaluation of the breasts. 
It can be used for checking breast cancer-like lesions in apparently healthy woman by finding nodules or calcifica-
tions. Exposure to this radiation rarely causes cancer, unless performed with a high periodic frequency whereby 
risk will increase. Besides being considered painful, relatively expensive, and a source of much discomfort and 
even embarrassment to patients, its sensitivity varies from 88 to 93%, while its specificity varies from 85 to 94%6. 
Such statistical metrics demonstrate the proportion of women with breast cancer who will present a positive 
mammogram signalling disease presence, and the rate of women without breast cancer who will have a normal 
mammography,  respectively6. Some breast cancer screening tests also include breast self-examination (BSE), 
clinical examination of breasts (CBE), nuclear magnetic resonance (NMR), and ultrasonography. However, the 
time from initial patient examination until diagnosis can be too lengthy; about 70% of breast cancer cases lead 
to complete removal of the breast(s). Many examinations are required to identify the presence of neoplasm: 
mammogram, breast exam, biopsy, magnetic resonance imaging (MRI) and ultrasound.
Infrared (IR) spectroscopy is a vibrational technique capable of analysing biomolecules, such as nucleic acids 
(asymmetric  PO2− in DNA and RNA at ~ 1,225 cm−1), carbohydrates (C–O stretching at ~ 1,155 cm−1), proteins 
(amide II at ~ 1,550 cm−1 and amide I at ~ 1,660 cm−1) and lipids (C=C stretching at ~ 1,750 cm−1), that exhibit 
characteristic features in the IR  region7. Attenuated total reflection Fourier-transform IR (ATR-FTIR) spectros-
copy has been used to analyse several biofluids due to its fast spectral acquisition, minimum sample preparation 
and sample volume, and its non-destructive nature to the  sample8. Recent research is progressing gradually 
in which excellent diagnostic results compared to traditional methods have been obtained in various types of 
cancer such as  ovarian9,  cervical10, and  prostate11; additionally, to diagnosis neurodegenerative diseases such as 
Alzheimer’s12. Herein, we present the results of using ATR-FTIR spectroscopy together with chemometrics for 
classification of patients with breast cancer in a large-scale screening program using blood biopsies.
Results
The FTIR spectral data in the fingerprint region (900–1,800 cm−1) were pre-processed by Savitzky–Golay smooth-
ing (window of 7 points, 2nd order polynomial fitting) followed by AWLS baseline correction and normalization 
to the Amide I peak (1,650 cm−1). The raw and pre-processed spectral data are shown in Fig. 1, where visual 
overlaps between breast cancer and healthy control spectra are present throughout the whole spectral region 
indicating the need of chemometric techniques to distinguish samples in such complex matrices. The pre-
processed spectral data underwent chemometric analysis by several classification techniques (Table 1). Amongst 
the classification techniques tested, SPA-SVM presented the best classification performance with accuracy of 
92.9% (94% sensitivity and 91% specificity) to detect breast cancer samples based on an external test set (15% 
of samples, n = 71 patients). ~ 70% of samples (n = 334 patients) were used for model construction and another 
15% for internal validation (n = 71 patients). Overall classification performance represented by the F-Score and 
G-Score values was good (93%), indicating equal performance with or without considering imbalanced data. 
Figure 2 shows the receiver operating characteristic (ROC) curve for all models. The best ROC curve (area under 
the curve [AUC] = 0.929) was found for SPA-SVM, indicating an excellent predictive performance. PCA-SVM 
(AUC = 0.886) and GA-SVM (AUC = 0.871) were, respectively, the second and third best classification algorithms, 
demonstrating a good classification performance.
The spectral variables selected by the best classification model (SPA-SVM) are shown in Fig. 3. In total, 16 
wavenumbers (901, 959, 980, 999, 1,018, 1,277, 1,364, 1,402, 1,464, 1,489, 1582, 1,311, 1626, 1643, 1661, and 
Figure 1.  ATR-FTIR spectra of plasma samples in the bio-fingerprint region (1,800–900 cm−1). (a) Raw spectral 
data for breast cancer (BC) and healthy controls (HC) samples; (b) pre-processed spectral data (Savitzky–Golay 
smoothing [window of 7 points, 2nd order polynomial fitting] followed by AWLS baseline correction and 
normalization to the Amide I peak) for breast cancer (BC) and healthy controls (HC) samples.
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1742 cm−1) were responsible for class differentiation using SPA-SVM. The tentative biochemical assignments of 
these variables based on Movasaghi et al.13 are shown in Table 2.
Discussion
Breast cancer accounts for approximately 15% of all female cancer deaths and has a 5-years survival rate ranging 
from approximately 40% in low-income countries to ≥ 80% in developing  contruies14. Its incidence is continually 
increasing worldwide. This is partly due to a change in the distribution of risk factors: e.g., in developed countries 
such as the UK, there have been significant increases in women giving birth later in life and in the number of 
Table 1.  Statistical results in % for the test set using the PCA-LDA/QDA/SVM, SPA-LDA/QDA/SVM and 
GA-LDA/QDA/SVM to discriminate healthy controls and breast cancer samples. AC, Accuracy; SENS, 
Sensitivity; SPEC, Specificity; YOU, Youden’s Index; PPV, Positive predictive value; NPV, Negative predictive 
value. The best model (SPA-SVM) is in bold.
Model AC SENS SPEC YOU PPV NPV F-score G-score
PCA-LDA 65.7 82.9 486 31.4 61.7 73.9 61.2 63.4
PCA-QDA 65.7 82.9 48.6 31.4 61.7 73.9 61.2 63.4
PCA-SVM 88.6 91.4 85.7 77.1 86.5 90.9 88.5 88.5
SPA-LDA 68.6 80.0 57.1 37.1 65.1 74.1 66.7 67.6
SPA-QDA 74.3 85.7 62.9 48.6 69.8 81.5 72.5 73.4
SPA-SVM 92.9 94.3 91.4 85.7 91.7 94.1 92.8 92.8
GA-LDA 75.7 74.3 77.1 51.4 76.5 75.0 75.7 75.7
GA-QDA 72.9 71.4 74.3 45.7 73.5 72.2 72.8 72.8
GA-SVM 87.1 88.6 85.7 74.3 86.1 88.2 87.1 87.1
Figure 2.  Receiver operating characteristic (ROC) curve. Where, PCA-LDA: principal component analysis 
linear discriminant analysis; PCA-QDA: principal component analysis quadratic discriminant analysis; PCA-
SVM: principal component analysis support vector machines; SPA-LDA: successive projections algorithm linear 
discriminant analysis; SPA-QDA: successive projections algorithm quadratic discriminant analysis; SPA-SVM: 
successive projections algorithm support vector machines; GA-LDA: genetic algorithm linear discriminant 
analysis; GA-QDA: genetic algorithm quadratic discriminant analysis; GA-SVM: genetic algorithm support 
vector machines. AUC: area under the curve.
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women childless by age 45 years. In addition, there has been an increasing adoption of Westernized lifestyles in 
developing  countries14, which may be a risk factor for breast cancer.
Mammography-based breast cancer screening is a common practice for early detection of breast cancers, 
where its efficiency has been demonstrated in randomized controlled trials and observational studies; hence, most 
organizations that issue recommendations endorse regular mammography as an important part of preventive 
 care15. However, although mammography-based breast cancer screening is associated with reduced morbidity 
and mortality, the majority of women who undergo screening will not develop breast cancer in their  lifetime15. 
In addition to the low risk of cumulative exposure to radiation over time and the great discomfort or shame 
associated with mammography-based screening, false positive results may lead to additional tests and investiga-
tions potentially causing psychological distress and anxiety. Conversely, negative results (i.e., where no signs of 
abnormality are found in the screening) may falsely reassure women when cancer is actually  present14. Moreover, 
mammography-based screening may also not benefit all women who are diagnosed with breast cancer, since it 
may lead to harm in women who undergo further biopsy for abnormalities that may not be breast  cancer15. For 
these reasons, less invasive and more accurate breast cancer screening strategies are urgently needed.
Figure 3.  Selected wavenumbers by the successive projections algorithm support vector machines (SPA-SVM) 
model.
Table 2.  Selected wavenumbers by the SPA-SVM to distinguish healthy controls and breast cancer samples.
Selected wavenumber  (cm−1) Tentative assignment
901 Phosphodiester (absorbances due to collagen and glycogen)
959 Symmetric stretching vibration of  n1PO4
980 OCH3 (polysaccharides)
999 Ring stretching vibrations mixed strongly with CH in plane bending
1,018 n(CO), n(CC), d(OCH), ring (polysaccharides, pectin)
1,277 Vibrational modes of collagen
1,311 Amide III band components of proteins
1,364 Stretching C–O, deformation C–H, deformation N–H
1,402 Symmetric  CH3 bending modes of the methyl groups of proteins
1,464 CH2 scissoring mode of the acyl chain of lipid
1,489 In-plane CH bending vibration
1582 Ring C–C stretch of phenyl
1626 Peak of nucleic acids due to the base carbonyl stretching and ring breathing mode
1643 Amide I band (arises from C=O stretching vibrations)
1661 n(C=C) cis in lipids and fatty acids
1742 C=O stretching mode of lipids
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Herein, ATR-FTIR spectroscopy in conjunction with chemometric techniques was used to detect breast 
cancer in a total cohort of 476 patients recruited over 2 years for an early-stage breast cancer screening program 
in Natal, Brazil. Breast cancer detection among normal samples was successfully performed based on the blood 
plasma spectra with 93% accuracy (94% sensitivity, 91% specificity, AUC = 0.929) in an external (blind) cohort 
of 71 patients using the SPA-SVM algorithm. Sixteen spectral features were responsible for class differentiation 
in the fingerprint region (Table 2). These are predominantly associated with phosphodiesters (P–O vibrations), 
polysaccharides (C–O stretching), proteins  (CH3 bending, Amide III, Amide I band), nucleic acids (C=O stretch-
ing and C–C ring breathing mode), and lipids (C=O stretching and (C=C)cis). C–O vibrations in carbohydrates, 
P–O vibrations in phosphodiesters, and proteins vibrations; these have been previously associated with breast 
cancer in  serum15,16. Serum applications for breast cancer detection have been performed using IR spectroscopy 
by Backhaus et al.15, where 98% sensitivity and 95% specificity (using cluster analysis) and 92% sensitivity and 
100% specificity [using artificial neural networks (ANN)] was obtained in a study carried out with 196 patients. 
Likewise, Elmi et al.16 detected breast cancer in serum-based IR spectroscopy with 76% sensitivity and 72% 
specificity for breast cancer cases using principal component analysis linear discriminant analysis (PCA-LDA) 
in a study with 86 samples (43 breast cancer, 43 healthy controls). The results reported herein are higher tak-
ing into consideration the large number of patients, where the sensitivity and specificity are found to be > 90%; 
being comparable to results obtained by more sophisticated methods such as using quantum cascade laser IR 
imaging, where sensitivity and specificity has been reported at 94% and 86%, respectively, using a random forest 
 classifier17. However, there are no studies reporting breast cancer screening based on plasma samples using IR 
spectroscopy for a big cohort of samples. Herein, 476 patients were studied resulting in a diagnostic accuracy, 
sensitivity and specificity above 90% for cancer detection.
Methods
Samples. In this study, we evaluated two groups of women. The first, Breast Cancer (BC), refers to a group 
of women diagnosed with breast cancer, with or without neoadjuvant treatment, and were collected by profes-
sionals trained at the Liga Contra o Câncer Hospital (Natal/RN, Brazil), during a period of 2 years. The second, 
Healthy Controls (HC), refers to a group of women with no previous or current diagnosis of breast cancer, col-
lected at the Prontoclínica Dr. Paulo Gurgel (Natal/RN, Brazil), during the same time period. In both groups, 
patients were > 18 years old, and family history related to some type of cancer was not taken into account. The 
Institutional Ethics Committee for Human Research of the Hospital Universitário Onofre Lopes (HUOL), of 
the Federal University of Rio Grande do Norte (UFRN), Brazil, approved this study (Ethical Approval Num-
ber—44113115.1.1001.5292) and informed consent was obtained from all subjects. Also, all the methods carried 
out in this study were by the approved guidelines. Samples from both groups were obtained after the reading 
of a Free Informed Consent Form and signature of the patients. Vacutainer tubes BD with 5 mL EDTA were 
used with disposable vacuum syringes. Thereafter, they were centrifuged for 10  min, and frozen at approxi-
mately − 20 °C until the time of analysis. A total of 476 samples were obtained.
AtR-ftiR spectroscopy. The samples were removed from the freezer 15 min before analysis to allow thaw-
ing. Samples were randomized and, to minimize temporal or instrumental effects, a similar number of samples 
from both groups were measured on each day. The absorption spectra were obtained using an attenuated total 
reflection Fourier-transform infrared (ATR-FTIR) spectrometer model IRAffinity-1S (Shimadzu Corp., Kyoto, 
Japan). The spectra were obtained in the range between 600 and 4,000 cm−1, with 32 co-added scans and 4 cm−1 
spectral resolution (2 cm−1 data spacing). The ATR crystal was cleaned with alcohol (70% v/v) and acetone (P.A.) 
for each new sample and before setting the new background. A 10-μL staken performed. This procedure was 
repeated in triplicate. The measurement time for each sample was approximately 5 min.
Three spectra collected per sample were first averaged and the following pre-processing was applied 
to the dataset: truncation to the biofingerprint region (900–1800 cm−1 with 468 wavenumber data points), 
Savitzky–Golay (SG) smoothing to remove random noise (window = 15 points, 2nd order polynomial fitting), 
automatic weighted least squares baseline correction, and normalization to the Amide I peak (1,650 cm−1).
Data analysis. The spectral data import, pre-processing and construction of multivariate classification 
models were performed using the MATLAB R2014b environment version 8.4 (MathWorks, Inc., Natick, USA) 
with the PLS-Toolbox version 7.9.3 (Eigenvector Research, Inc., Manson, USA) and laboratory-made routines. 
All spectra were organized into a data matrix, where samples were represented as rows and the wavenumbers 
as columns. The samples were divided into three different subsets by the Kennard–Stone (KS) sample selection 
 algorithm18: training (70%), validation (15%) and test (15%) sets. The training set was used to build the clas-
sification models, while the validation set to optimize and evaluate its internal performance. Finally, the test set 
was used to evaluate the model classification performance towards external samples.
The computational analysis consisted of testing three algorithms for feature extraction and selection: principal 
component analysis (PCA)19, successive projections algorithm (SPA)20 or genetic algorithm (GA)21; followed by 
discriminant analysis classifiers: linear discriminant analysis (LDA)22, quadratic discriminant analysis (QDA)22 
or support vector machines (SVM)23. These algorithms were coupled as feature extraction/selection and clas-
sification as: PCA-LDA, PCA-QDA, and PCA-SVM; SPA-LDA, SPA-QDA, and SPA-SVM; and GA-LDA, GA-
QDA, and GA-SVM.
PCA is a feature extraction method widely used for data  reduction19. It decomposes the pre-processed spec-
tral data into a small number of principal components (PCs) containing scores (variance on sample direction) 
and loadings (variance on wavenumber direction). The PCA scores are used to assess similarities/dissimilarities 
between the samples, while the PCA loadings to investigate potential spectral markers. SPA is a forward feature 
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selection  method20. Its purpose is to select wavenumbers whose information content is minimally redundant 
in order to solve co-linearity problems. The model starts with one wavenumber, then incorporates a new one 
at each iteration until it reaches a specified number of wavenumbers. SPA does not modify the original data 
space as PCA does. In SPA, the projections are used only for variable selection purposes. Thus, the relationship 
between the spectral variables is preserved.
On the other hand, the GA uses a combination of selection, recombination and mutation to select a set 
of  variables21. The GA aims to reduce the original data in a few number of wavenumbers following a natural 
evolutionary process based on Darwin’s theory where the best set of wavenumbers, in this case considered as a 
chromosome, is selected according to a fitness function. The GA routine was carried out during 100 generations 
with 200 chromosomes each where mutation and crossover probabilities were set to 10% and 60%, respectively. 
The best solution in GA, in terms of fitness value, is obtained after three realizations starting from different 
random initial populations. Similarly to SPA, GA also does not modify the original data space as PCA does. The 
SPA/GA fitness is calculated as the inverse of the cost function G , which is defined as  follows24:
where NV is the number of validation samples and gn is defined as:
where the numerator is the squared Mahalanobis distance between object xn of class index I(n) and the sample 
mean mI(n) of its true class; and the denominator is the squared Mahalanobis distance between object xn and 
the centre of the closest wrong class. The advantages of these variable reduction methods (PCA, SPA and GA) 
prior discriminant analysis lie in the fact that they efficiently remove co-linearity in the dataset, thus preserving 
only non-redundant information; they solve dimensionality problems for LDA and QDA; and they speed-up 
the computational time for SVM.
LDA and QDA are discriminant analysis classifiers based on a Mahalanobis distance calculation between the 
samples; where the main difference between them is that LDA assumes classes having similar variance structures, 
hence, using a pooled covariance matrix, while QDA assumes classes having different variance structures therefor 
using the variance–covariance matrix of each class individually for  calculation22. The LDA classification score for 
sample i of class k ( Lik ) is calculated for a given class sample in a non-Bayesian form by the following  equation22,25:
where xi is a vector with the input variables for sample i ; xk is the mean of class k ; and Cpooled is the pooled covari-
ance matrix between the classes. The QDA classification score for sample i of class k ( Qik ) is estimated using the 
variance–covariance for each class k ( Ck ) in a non-Bayesian form as  follows22,25:
SVM is a powerful supervised classification method that nonlinearly transform the input sample space into a 
feature space using a kernel function that maximizes the margins of separation between the sample groups, and 
then it constructs a linear hyperplane that discriminates the samples from different groups in this feature  space23. 
In this study, a radial basis function (RBF) kernel was utilized. The RBF is calculated as  follows26:
where xi and z j are sample measurements vectors, and γ is a tuning parameter that controls the RBF width. In 
the RBF kernel function, the γ parameter was set to 1. The SVM classification rule is obtained by the following 
 equation26:
where NSV  is the number of support vectors; αi is the Lagrange multiplier; yi is the class membership (± 1); 
k
(
xi , zj
)
 is the kernel function; and b is the bias parameter. These SVM parameters were obtained and optimized 
via an external validation set.
Quality performance. The statistical parameters for the evaluation of the classification models were: 
accuracy (AC), sensitivity (SENS), specificity (SPEC), Youden’s Index (YOU), positive predictive value (PPV), 
negative predictive value (NPV), F-Score and G-Score. AC is related to the percentage of correct classification 
achieved by the model. SENS measures the proportion of positive results that are correctly identified while SPEC 
measures the proportion of negative results that are correctly identified. In this study, when we have a case–con-
trol patients approach, sensitivity can be understood as the probability to find a positive result when the disease 
is present, while specificity can be understood as the probability to find a negative result when the disease is not 
present. Youden’s index (YOU) evaluates the classifier’s ability to avoid failure. The PPV measures the proportion 
(1)G =
1
NV
NV∑
n=1
gn
(2)gn =
r2
(
xn,mI(n)
)
minI(m)�=I(n)r2
(
Xn,mI(m)
)
(3)Lik = (xi − xk)TC−1pooled(xi − xk)
(4)Qik = (xi − xk)TC−1k (xi − xk)
(5)k
(
xi , z j
)
= exp
(
−γ
∣∣∣∣∣∣xi − z2j ∣∣∣∣∣∣)
(6)f (x) = sign
(
NSV∑
i=1
αiyik
(
xi , z j
)
+ b
)
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of positives that are correctly assigned (its value varies between 0 and 1); the NPV measures the proportion of 
negatives that are correctly assigned (its value varies between 0 and 1); the F-score represents the weighted aver-
age of the precision and sensitivity; and the G-score accounts for the model precision and sensitivity without the 
influence of positive and negative class  sizes27. These parameters are calculated based on the equations shown 
in Table 3. In addition, a receiver operating characteristics (ROC) curve was generated to all models. The area 
under curve (AUC) value was calculated to evaluate how well the model can distinguish the samples between 
the different classes analysed.
Received: 22 March 2020; Accepted: 17 June 2020
References
 1. BRASIL. Instituto Nacional de Câncer José Alencar Gomes da Silva/Ministério da Saúde. Estimativa 2018: incidência de câncer 
no Brasil. Rio de Janeiro: INCA (2017). https ://www.inca.gov.br/sites /ufu.sti.inca.local /files //media /docum ent//estim ativa -incid 
encia -de-cance r-no-brasi l-2018.pdf. Accessed 26 Dec 2019.
 2. BRASIL. Instituto Nacional de Câncer José Alencar Gomes da Silva/Ministério da Saúde. Câncer de mama: é preciso falar disso. 
Rio de Janeiro: INCA (2014). https ://www.inca.gov.br/sites /ufu.sti.inca.local /files //media /docum ent//carti lha-cance r-de-mama-
vamos -falar -sobre -isso2 014.pdf. Accessed 26 Dec 2019.
 3. Castro, R. Câncer na Mídia: uma Questão de Saúde Pública. Rev. Br. Cancerol. 55, 41–48 (2009).
 4. Facina, T. Estimativa 2014—Incidência de Câncer no Brasil. Rev. Br. Cancerol. 60, 63 (2014).
 5. BRASIL. Plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil 2011–2022. 
Brasília: Ministério de Saúde (2011). https ://bvsms .saude .gov.br/bvs/publi cacoe s/plano _acoes _enfre nt_dcnt_2011.pdf. Accessed 
26 Dec 2019.
 6. BRASIL. Ministério da Saúde. Instituto Nacional de Câncer. Mamografia: da prática ao controle. Rio de Janeiro: INCA (2007). 
https ://bvsms .saude .gov.br/bvs/publi cacoe s/quali dade_mamog rafia .pdf. Accessed 26 Dec 2019.
 7. Baker, M. J. et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nat. Protoc. 9, 1771–1791. https ://doi.
org/10.1038/nprot .2014.110 (2014).
 8. Mitchell, A. L., Gajjar, K. B., Theophilou, G., Martin, F. L. & Martin-Hirsch, P. L. Vibrational spectroscopy of biofluids for disease 
screening or diagnosis: translation from the laboratory to a clinical setting. J. Biophotonics 7, 153–165. https ://doi.org/10.1002/
jbio.20140 0018 (2014).
 9. Theophilou, G., Lima, K. M. G., Martin-Hirsch, P. L., Stringfellow, H. F. & Martin, F. L. ATR-FTIR spectroscopy coupled with 
chemometric analysis discriminates normal, borderline and malignant ovarian tissue: classifying subtypes of human cancer. Analyst 
141, 585–594. https ://doi.org/10.1039/C5AN0 0939A (2016).
 10. Neves, A. C. O. et al. ATR-FTIR and multivariate analysis as a screening tool for cervical cancer in women from northeast Brazil: 
a biospectroscopic approach. RSC Adv. 6, 99648–99655. https ://doi.org/10.1039/C6RA2 1331F (2016).
 11. Siqueira, L. F. S. & Lima, K. M. G. A decade (2004–2014) of FTIR prostate cancer spectroscopy studies: an overview of recent 
advancements. Trends Analyt. Chem. 82, 208–221. https ://doi.org/10.1016/j.trac.2016.05.028 (2016).
 12. Paraskevaidi, M. et al. Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood. Proc. Natl. Acad. Sci. 
USA 114, E7929–E7938. https ://doi.org/10.1073/pnas.17015 17114 (2017).
 13. Movasaghi, Z., Rehman, S. & ur Rehman, I. Fourier transform infrared (FTIR) spectroscopy of biological tissues. Appl. Spectrosc. 
Rev. 43, 134–179. https ://doi.org/10.1080/05704 92070 18290 43 (2008).
 14. Harkness, E. F., Astley, S. M. & Evans, D. G. Risk-based breast cancer screening strategies in women. Best Pract. Res. Clin. Obstet. 
Gynaecol. https ://doi.org/10.1016/j.bpobg yn.2019.11.005 (2019).
 15. Smith, R. A. et al. American cancer society guidelines for breast cancer screening: update 2003. CA Cancer J. Clin. 53, 141–169. 
https ://doi.org/10.3322/canjc lin.53.3.141 (2003).
 16. Backhaus, J. et al. Diagnosis of breast cancer with infrared spectroscopy from serum samples. Vib. Spectrosc. 52, 173–177. https ://
doi.org/10.1016/j.vibsp ec.2010.01.013 (2010).
 17. Elmi, F., Movaghar, A. F., Elmi, M. M., Alinezhad, H. & Nikbakhsh, N. Application of FT-IR spectroscopy on breast cancer serum 
analysis. Spectrochim. Acta A Mol. Biomol. Spectrosc. 187, 87–91. https ://doi.org/10.1016/j.saa.2017.06.021 (2017).
 18. Pilling, M. J., Henderson, A. & Gardner, P. Quantum cascade laser spectral histopathology: breast cancer diagnostics using high 
throughput chemical imaging. Anal. Chem. 89, 7348–7355. https ://doi.org/10.1021/acs.analc hem.7b004 26 (2017).
 19. Kennard, R. W. & Stone, L. A. Computer aided design of experiments. Technometrics 11, 137–148. https ://doi.org/10.1080/00401 
706.1969.10490 666 (1969).
 20. Bro, R. & Smilde, A. K. Principal component analysis. Anal. Methods 6, 2812–2831. https ://doi.org/10.1039/C3AY4 1907J (2014).
 21. Soares, S. F. C., Gomes, A. A., Araujo, M. C. U., Galvão Filho, A. R. & Galvão, R. K. H. The successive projections algorithm. Trends 
Anal. Chem. 42, 84–98. https ://doi.org/10.1016/j.trac.2012.09.006 (2013).
Table 3.  Equations to calculate the figures of merit for model evaluation. FN stands for false negative, FP for 
false positive, TP for true positive, and TN for true negative.
Parameter (%) Equation
Accuracy (AC) TP+TN
TP+FP+TN+FN
× 100
Sensitivity (SENS) TP
TP+FN
× 100
Specificity (SPEC) TN
TN+FP
× 100
Youden’s index (YOU) SENS− (100− SPEC)
Positive predictive value (PPV)
(
TP
TP+FP
)
× 100
Negative predictive value (NPV)
(
TN
TN+FN
)
× 100
F-score
(
2× SENS× SPEC
SENS+SPEC
)
G-score
√
SENS × SPEC
8Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12818  | https://doi.org/10.1038/s41598-020-69800-7
www.nature.com/scientificreports/
 22. McCall, J. Genetic algorithms for modelling and optimisation. J. Comput. Appl. Math. 184, 205–222. https ://doi.org/10.1016/j.
cam.2004.07.034 (2005).
 23. Morais, C. L. M. & Lima, K. M. G. Principal component analysis with linear and quadratic discriminant analysis for identification 
of cancer samples based on mass spectrometry. J. Br. Chem. Soc. 29, 472–481. https ://doi.org/10.21577 /0103-5053.20170 159 (2018).
 24. Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273–297. https ://doi.org/10.1023/A:10226 27411 411 (1995).
 25. Siqueira, L. F. S., Araújo Júnior, R. F., de Araújo, A. A., Morais, C. L. M. & Lima, K. M. G. LDA vs. QDA for FT-MIR prostate cancer 
tissue classification. Chemom. Intell. Lab. Syst. 162, 123–129. https ://doi.org/10.1016/j.chemo lab.2017.01.021 (2017).
 26. Dixon, S. J. & Brereton, R. G. Comparison of performance of five common classifiers represented as boundary methods: Euclidean 
distance to centroids, linear discriminant analysis, quadratic discriminant analysis, learning vector quantization and support vector 
machines, as dependent on data structure. Chemom. Intell. Lab. Syst. 95, 1–17. https ://doi.org/10.1016/j.chemo lab.2008.07.010 
(2009).
 27. Morais, C. L. M., Costa, F. S. L. & Lima, K. M. G. Variable selection with a support vector machine for discriminating Cryptococcus 
fungal species based on ATR-FTIR spectroscopy. Anal. Methods 9, 2964–2970. https ://doi.org/10.1039/C7AY0 0428A (2017).
 28. Morais, C. L. M., Lima, K. M. G. & Martin, F. L. Uncertainty estimation and misclassification probability for classification 
models based on discriminant analysis and support vector machines. Anal. Chim. Acta 1063, 40–46. https ://doi.org/10.1016/j.
aca.2018.09.022 (2019).
Acknowledgements
D.L.D. Freitas would like to thank CAPES/PPGQ/UFRN for financial support. C.L.M. Morais would like to thank 
the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil (Grant 88881.128982/2016-
01), for his research grant. The authors greatly appreciate the contribution of all women involved in this study, and 
the collaboration of the Universidade Federal do Rio Grande do Norte (UFRN), Liga Contra o Câncer Hospital 
(Natal, Brazil), and the Prontoclínica Dr. Paulo Gurgel (Natal, Brazil) for the support during sample acquisition.
Author contributions
D.L.D.F was responsible for the construction of the chemometric models and multivariate analysis. I.M.C and 
D.L.D.F were responsible for acquiring the spectral data and writing the first draft of the manuscript. P.P.S, 
N.R.S.W and M.B.C.A were responsible for collecting the patients’ samples. C.L.M.M. and F.L.M. provided 
chemometric support and finalised the manuscript. T.B.P.L and K.M.G.L. supervised the project and revised 
the manuscript.
competing interests 
The authors declare no competing interests.
Additional information
Correspondence and requests for materials should be addressed to K.M.G.L.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this license, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
